Page last updated: 2024-08-24

fluorodeoxyglucose f18 and 1-(3,4-dimethoxyphenethyl)-4-(3-phenylpropyl)piperazine dihydrochloride

fluorodeoxyglucose f18 has been researched along with 1-(3,4-dimethoxyphenethyl)-4-(3-phenylpropyl)piperazine dihydrochloride in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
de Jong, JR; Dierckx, RA; Elsinga, PH; Ishiwata, K; Shiba, K; van Waarde, A	1

Other Studies

1 other study(ies) available for fluorodeoxyglucose f18 and 1-(3,4-dimethoxyphenethyl)-4-(3-phenylpropyl)piperazine dihydrochloride

Article	Year
Rapid reduction of sigma1-receptor binding and 18F-FDG uptake in rat gliomas after in vivo treatment with doxorubicin. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2007, Volume: 48, Issue:8 Topics: Animals; Antibiotics, Antineoplastic; Carbon Radioisotopes; Doxorubicin; Fluorodeoxyglucose F18; Glioma; Male; Piperazines; Positron-Emission Tomography; Rats; Rats, Wistar; Receptors, sigma; Tissue Distribution	2007

Article

Year

Rapid reduction of sigma1-receptor binding and 18F-FDG uptake in rat gliomas after in vivo treatment with doxorubicin.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2007, Volume: 48, Issue:8

Topics: Animals; Antibiotics, Antineoplastic; Carbon Radioisotopes; Doxorubicin; Fluorodeoxyglucose F18; Glioma; Male; Piperazines; Positron-Emission Tomography; Rats; Rats, Wistar; Receptors, sigma; Tissue Distribution

2007